Finance

Lists
Why is 002422 down 2.78%?
Dive Deeper
002422:SHE
Sichuan Kelun Pharmaceutical Co Ltd
CN¥40.15
-2.78%
(-1.15) 1D
Oct 30, 3:04:15 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002422...
Open
CN¥41.10
High
CN¥41.70
Low
CN¥39.95
Mkt. cap
63.87B
Avg. vol.
19.81M
Volume
17.26M
Dividend
1.48%
Quarterly dividend
CN¥0.15
Ex-dividend date
Oct 21, 2026
P/E ratio
34.84
52-wk high
CN¥52.78
52-wk low
CN¥28.14
EPS
CN¥1.15
Shares outstanding
1.59B
No. of employees
20K
Open
CN¥41.10
High
CN¥41.70
Low
CN¥39.95
Mkt. cap
63.87B
Avg. vol.
19.81M
Volume
17.26M
Dividend
1.48%
Quarterly dividend
CN¥0.15
Ex-dividend date
Oct 21, 2026
P/E ratio
34.84
52-wk high
CN¥52.78
52-wk low
CN¥28.14
EPS
CN¥1.15
Shares outstanding
1.59B
No. of employees
20K
News stories
From web sources and news partners
About Sichuan Kelun Pharmaceutical Co Ltd
CEO-
Employees20.1K
Founded1996
Headquarters-
SectorPharmaceutical industry
Websitekelun.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
5.24B
4.26B
4.58B
4.27B
Cost of goods sold
2.85B
2.33B
2.36B
2.21B
Cost of revenue
2.85B
2.33B
2.36B
2.21B
Research and development expenses
572.64M
586.14M
626.45M
472.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.17B
992.40M
1.11B
1.09B
Operating expense
1.97B
1.66B
1.75B
1.48B
Total operating expenses
4.82B
3.99B
4.11B
3.69B
Operating income
416.66M
271.42M
473.04M
582.75M
Other non operating income
146.54M
82.48M
-86.55M
528.06M
EBT including unusual items
754.91M
441.05M
1.11B
425.95M
EBT excluding unusual items
562.20M
407.20M
405.94M
1.19B
Income tax expense
122.46M
-31.65M
158.57M
77.57M
Effective tax rate
16.22%
-7.18%
14.26%
18.21%
Other operating expenses
233.64M
66.32M
507.56K
-54.75M
Net income
501.27M
453.70M
674.07M
339.26M
Net profit margin
9.57%
10.65%
14.72%
7.94%
Earnings per share
-
-
-
-
Interest and investment income
63.65M
76.41M
57.89M
66.04M
Interest expense
-19.09M
-23.12M
-24.71M
-
Net interest expenses
44.56M
53.29M
33.18M
66.04M
Depreciation and amortization charges
-
-
-
-
EBITDA
739.75M
594.51M
806.81M
905.84M
Gain or loss from assets sale
-5.32M
-
-1.68M
1.68M
Upcoming events
AI content may include mistakes. Learn more
Google apps